Coonatra
Rail, Bus & Taxi · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.coonatra.comRevenue
$5.9 MillionIndustry
About Coonatra
Coonatra Org Chart
Is Coonatra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Coonatra has new funding data
Click to see if Coonatra had a recent Job posting/layoffs
Earning: See what the market has to say on Coonatra recently announced quarterly report
Coonatra, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Coonatra has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Coonatra launches new products
Congratulate Masked Content for being promoted to Masked Content at Coonatra
Website visits: Recent activity has been detected on your website
Check out if Coonatra is spiking on competitors!
Recommended Actions
Find VP level buyers at Coonatra
Find more new buyers
Company Profile Activity
Activity Insights
Coonatra is experiencing very low activity levels compared to other companies in the Transportation sector.
What does this means?
Coonatra is drawing exceptional interest within the Transportation industry, suggesting notable developments or strong market momentum, learn more about Coonatra.
Coonatra Tech Stack
A closer look at the technologies used by Coonatra
Top Rail, Bus & Taxi Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Coonatra
Coonatra is a transportation company that provides public land transport services for passengers, focusing on meeting the mobility needs of its users with responsibility, agility, and efficiency. The company operates various routes including Floresta-San Juan, Calasanz-Boston, and Circular Coonatra. Coonatra seeks to hire individuals with C2 and C3... Read More